How Parkinson’s Disease Affects Swallowing

Parkinson’s disease (PD) is a progressive neurodegenerative condition whose impact on swallowing is frequently underestimated by patients and caregivers alike. Research indicates that up to 70–80% of people with Parkinson’s disease will develop some degree of dysphagia during the course of their illness, yet many never receive a formal swallowing assessment because symptoms develop gradually.

Bradykinesia and Its Effect on Eating

Bradykinesia — slowness of movement — is the hallmark motor symptom of Parkinson’s disease and directly affects every stage of the swallowing sequence:

• Prolonged oral preparation: Chewing becomes slower and weaker, dramatically increasing the time food remains in the mouth
• Impaired tongue propulsion: The tongue’s posterior drive to push the food bolus towards the pharynx is reduced, producing a characteristic “repetitive rolling” pattern
• Delayed pharyngeal swallow trigger: The interval between the food bolus reaching the posterior pharyngeal wall and the swallowing reflex being triggered is prolonged, increasing aspiration risk

The Effect of Tremor on Self-Feeding

Hand and head tremor directly compromises the patient’s ability to feed independently: food spills from utensils, soup and drinks are difficult to transport steadily, and the total time required for self-feeding increases substantially. An occupational therapist can assess and recommend weighted utensils and non-slip placemats to help preserve independent eating for longer.

Reduced Laryngeal Sensitivity

Laryngopharyngeal sensory function is often diminished in Parkinson’s disease. Patients may be unable to detect that food or liquid has entered the airway — the phenomenon known as silent aspiration. This means that the absence of coughing does not rule out ongoing aspiration and the risk of aspiration pneumonia. Waiting for coughing episodes before seeking assessment is particularly dangerous in this population.

Important notice: This guide provides general caregiver information and does not replace individualised assessment by a speech-language pathologist. People with Parkinson’s disease should receive regular SLP follow-up even in the absence of obvious swallowing symptoms.

Disease Stage and Dietary Adaptation

Early Stage (Hoehn & Yahr 1–2)

Dysphagia in early Parkinson’s disease is usually subtle but may already include slower chewing speed and mild oral residue. Recommended measures:

• Choose easily chewed textures: avoid particularly hard, dry or fibrous foods (celery, pineapple, crusty bread)
• Maintain adequate fluid intake: many PD patients reduce fluid intake due to drooling and effortful swallowing, leading to dehydration
• Establish a deliberate swallowing habit: after each mouthful of food or sip of liquid, consciously complete the swallow before taking the next

Middle Stage (Hoehn & Yahr 3)

Dysphagia typically worsens noticeably in the middle stage, and is often most pronounced during the medication Off period. Measures to consider:

• Consider transitioning to IDDSI Level 6 (Soft and Bite-Sized) or Level 5 (Minced and Moist)
• Drinks may require mild thickening (IDDSI Level 1–2)
• A formal clinical swallowing assessment by an SLP is strongly recommended; videofluoroscopic swallowing study (VFSS) may be indicated

Late Stage (Hoehn & Yahr 4–5)

Dysphagia is severe in the late stage, with high risks of aspiration and malnutrition:

• IDDSI Level 4 (Puréed) or lower is typically required
• Drinks usually need moderately thick to extremely thick consistency (IDDSI Level 3–4)
• Tube feeding options should be assessed, and end-of-life care planning should occur within a multidisciplinary team framework

Levodopa and Meal Timing: The Critical Role of Dietary Protein

Levodopa (marketed in Hong Kong as Madopar and co-preparations) is the cornerstone pharmacological treatment for Parkinson’s disease. Its absorption, however, is meaningfully affected by dietary protein — a fact with important implications for meal planning.

Why Protein Interferes with Levodopa Absorption

Levodopa is absorbed in the small intestine via the Large Neutral Amino Acid Transporter (LNAA). The large neutral amino acids produced by protein digestion compete with levodopa for the same transport mechanism, reducing drug absorption and causing inconsistent plasma levels.

Practical Recommendations (Drug Timing and Meals)

Eating during the On period (peak medication effect): tremor and bradykinesia are substantially reduced, swallowing is more coordinated, and a higher IDDSI texture level may be tolerable.

Eating during the Off period (medication trough): choose lower IDDSI texture levels, allow considerably more time per meal, and avoid foods requiring extensive chewing.

Swallowing Rehabilitation: LSVT and EMST

Hong Kong speech-language pathologists provide specialist swallowing rehabilitation programmes designed for Parkinson’s disease.

LSVT LOUD (Lee Silverman Voice Treatment)

LSVT LOUD is an intensive voice and speech treatment programme centred on “speaking loudly”. Research has demonstrated improvements in vocal loudness and laryngeal coordination in PD patients, with secondary benefits to swallowing function. The standard programme is four weeks of four sessions per week. Speech-language pathologists trained in LSVT LOUD are available at Queen Elizabeth Hospital (QEH), Prince of Wales Hospital (PWH) and selected private clinics in Hong Kong.

EMST (Expiratory Muscle Strength Training)

EMST uses a purpose-built threshold resistance device to train the expiratory muscle groups. Strengthening these muscles improves the ability to clear pharyngeal residue after swallowing and enhances cough effectiveness — reducing the severity of complications when aspiration does occur. Private speech-language pathologists can provide the training device and a personalised programme.

Specific Cantonese Food Challenges

Several traditional Cantonese foods present particular challenges for people with Parkinson’s disease:

Glutinous Rice Products

Tong yuan (glutinous rice balls), nian gao (New Year cake), and lo mai chi (glutinous rice dumplings) are extremely sticky and cohesive, requiring powerful tongue and pharyngeal coordination to swallow safely. Patients with Parkinson’s disease should avoid all unmodified glutinous rice products.

Skin-On Foods

Chicken skin, fish skin, and prawn shells are difficult to chew uniformly and create mixed textures that increase aspiration risk. All skin and shells should be removed before serving.

Fibrous Vegetables

Water spinach, celery and French beans are difficult to chew thoroughly. Substitute with more manageable vegetables such as steamed pumpkin, marrow (courgette) or steamed tofu, or steam other vegetables until very soft and chop finely.

Solid Ingredients in Cantonese Slow-Cooked Soups

Lotus root, radish, chestnuts and other solid ingredients in traditional Cantonese soups have inconsistent textures. These should be removed before serving; the strained broth (thickened as appropriate to the patient’s prescribed IDDSI liquid level) is safe.

Hong Kong Resources

HA Geriatrics and Neurology Speech-Language Therapy

The Hospital Authority (HA) provides speech-language therapy across all clusters. Parkinson’s disease patients can be referred by their neurologist or geriatrician. A baseline swallowing assessment early in the disease course — rather than waiting for symptoms — is recommended.

Key public hospitals with neurology and geriatric services:

• Kowloon Central Cluster: Queen Elizabeth Hospital (QEH)
• New Territories East Cluster: Prince of Wales Hospital (PWH)
• New Territories West Cluster: Tuen Mun Hospital (TMH)
• Hong Kong East Cluster: Pamela Youde Nethersole Eastern Hospital (PYNEH)

Hong Kong Parkinson Disease Foundation (HKPDF)

HKPDF is Hong Kong’s primary support organisation for people with Parkinson’s disease and their families. Services include:

• Caregiver support groups and educational workshops
• Physiotherapy and speech therapy referral information
• Website: hkpdf.org.hk
• Enquiry hotline: 2332 6030

Hong Kong Neurological Society

Provides information on the latest Parkinson’s disease treatment options and a specialist directory, helping patients access current swallowing management resources.

Frequently Asked Questions

Q: How early should a Parkinson’s disease patient receive a swallowing assessment?

A: A baseline swallowing assessment from a speech-language pathologist is recommended as early as possible after diagnosis — even before noticeable swallowing difficulties appear. This establishes an individual baseline. Annual reviews are appropriate thereafter, with earlier reassessment if symptoms worsen. Early intervention is associated with significantly slower deterioration of swallowing function.

Q: Can dysphagia in Parkinson’s disease improve?

A: Targeted swallowing rehabilitation programmes (LSVT LOUD, EMST) can produce measurable improvements, particularly in the early-to-middle disease stages. However, because Parkinson’s disease is progressive, the primary goal of rehabilitation is to slow deterioration rather than achieve complete reversal. Dietary texture modification provides ongoing safety throughout the disease course.

Q: How should mealtimes differ between On and Off periods?

A: During the On period (peak medication effect, improved motor control), swallowing coordination is better. Schedule the main meal of the day during this window and choose the highest IDDSI texture level that is safe for the patient. During the Off period (medication trough, tremor and rigidity worsened), move to lower IDDSI texture levels, avoid foods requiring extensive chewing, and allow substantially more time. Never rush eating during an Off period.

Q: Does drooling affect swallowing safety?

A: Drooling (sialorrhoea) in Parkinson’s disease occurs primarily because swallowing frequency is reduced rather than because saliva production is excessive. Accumulation of saliva in the oral cavity increases the risk of aspiration of oral secretions. Management strategies include conscious reminders to swallow every 30 seconds, maintaining good upright posture, and discussing pharmacological options (such as botulinum toxin injections into the salivary glands) with the attending neurologist.

Content reviewed regularly to reflect current clinical guidelines. Enquiries: [email protected].